GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Acquired by First Horizon Advisors Inc.

First Horizon Advisors Inc. lifted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 8.4% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 5,950 shares of the company’s stock after buying an additional 459 shares during the quarter. First Horizon Advisors Inc.’s holdings in GE HealthCare Technologies were worth $558,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in GEHC. Pathway Financial Advisers LLC purchased a new stake in shares of GE HealthCare Technologies in the 1st quarter valued at approximately $25,000. LGT Financial Advisors LLC raised its stake in shares of GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares in the last quarter. Fred Alger Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 2nd quarter valued at $26,000. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies in the 3rd quarter valued at $26,000. Finally, Ashton Thomas Securities LLC bought a new stake in GE HealthCare Technologies during the 3rd quarter worth about $26,000. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business’s stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.27% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Evercore ISI increased their target price on GE HealthCare Technologies from $98.00 to $102.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and decreased their target price for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. Wells Fargo & Company boosted their price target on GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Thursday, October 31st. JPMorgan Chase & Co. began coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price for the company. Finally, BTIG Research upgraded shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $94.36.

GE HealthCare Technologies Trading Down 3.0 %

GE HealthCare Technologies stock opened at $82.32 on Friday. The business has a 50-day simple moving average of $88.44 and a two-hundred day simple moving average of $83.57. GE HealthCare Technologies Inc. has a 52-week low of $66.39 and a 52-week high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The company has a market cap of $37.61 billion, a P/E ratio of 22.62, a P/E/G ratio of 2.96 and a beta of 1.24.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion during the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The company’s revenue for the quarter was up .9% on a year-over-year basis. During the same period last year, the company earned $0.99 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.29 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Shareholders of record on Friday, October 18th were issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.15%. The ex-dividend date of this dividend was Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is currently 3.30%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.